Cardinal Health, Inc. (NYSE:CAH) Stock Position Lessened by Kwmg LLC

Kwmg LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 2.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 118,836 shares of the company's stock after selling 3,309 shares during the quarter. Cardinal Health makes up approximately 1.7% of Kwmg LLC's holdings, making the stock its 17th largest holding. Kwmg LLC's holdings in Cardinal Health were worth $16,372,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Cardinal Health by 35.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock valued at $3,871,000 after purchasing an additional 8,471 shares in the last quarter. Consolidated Planning Corp boosted its position in shares of Cardinal Health by 40.0% in the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock worth $1,056,000 after buying an additional 2,552 shares during the period. Flputnam Investment Management Co. boosted its position in shares of Cardinal Health by 1.8% in the fourth quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock worth $21,358,000 after buying an additional 3,148 shares during the period. Huntington National Bank boosted its position in shares of Cardinal Health by 1.2% in the fourth quarter. Huntington National Bank now owns 10,920 shares of the company's stock worth $1,292,000 after buying an additional 128 shares during the period. Finally, JSF Financial LLC acquired a new position in Cardinal Health during the 4th quarter worth approximately $967,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently commented on the company. JPMorgan Chase & Co. boosted their price target on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Mizuho boosted their price target on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Finally, Bank of America upped their target price on Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a research report on Friday, April 11th. Three analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and an average price target of $149.50.

Cardinal Health Price Performance

Shares of CAH stock traded down $1.29 on Wednesday, hitting $154.19. 1,346,464 shares of the stock traded hands, compared to its average volume of 2,214,820. The company has a market capitalization of $36.80 billion, a PE ratio of 28.77, a PEG ratio of 1.49 and a beta of 0.66. The company's fifty day moving average is $142.49 and its 200 day moving average is $130.79. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $158.02.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm's revenue was up .0% on a year-over-year basis. During the same period in the prior year, the business earned $2.08 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date is Tuesday, July 1st. Cardinal Health's dividend payout ratio is presently 31.83%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.